위스콘신의 유방암 임상 시험
유방암 관련 연구 44개가 위스콘신 내 여러 지역에서 참여자를 모집하고 있습니다.
위스콘신의 도시
- Milwaukee연구 23개
- Madison연구 22개
- Green Bay연구 7개
- Sheboygan연구 6개
- La Crosse연구 6개
- Stevens Point연구 5개
- Wausau연구 5개
- Eau Claire연구 5개
- Oshkosh연구 5개
- Manitowoc연구 4개
- Racine연구 4개
- Neenah연구 4개
- Kenosha연구 4개
- Watertown연구 4개
공식 연구 텍스트(영어)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- 외 50개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06760819A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- University of Wisconsin, Madison
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07102381Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Wisconsin Institute for Medical Research, Madison
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06625775A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Milwaukee
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0039), Madison
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- University of Wisconsin-Madison ( Site 0024), Madison
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0040), Madison
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Milwaukee
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- University of Wisconsin, Madison
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- ThedaCare Physicians - Appleton North, Appleton
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- University of Wisconsin - Carbone Cancer Center, Madison
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Medical College of Wisconsin, Milwaukee
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Froedtert & MCW Cancer Center, Milwaukee
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Mayo Clinic Health System - Eau Claire, Eau Claire
- Mayo Clinic Health System - La Crosse, La Crosse
- University of Wisconsin Carbone Cancer Center- University Hospital, Madison
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
- Medical College of Wisconsin, Milwaukee
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07405801Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Wisconsin-Madison Carbone Cancer Center, Madison
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07287917Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- University of Wisconsin Carbone Cancer Center- University Hospital, Madison
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06982521Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Gunderson Health, La Crosse
피험자 모집 중관찰 연구
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07211178Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
- University of Wisconsin, Madison
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT04886531The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06995898Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- 외 59개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Sheboygan Cancer & Blood Specialists, Sheboygan
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612Study of 18F-FFNP Breast PET/MRI
- UW Carbone Cancer Center, Madison
피험자 모집 중2상
18세 이상 · 여성 · 2026. 8. 31. 업데이트됨 · NCT06086704Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017Biomarkers to Detect Endocrine Therapy Resistance
- UW Carbone Cancer Center, Madison
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06067503Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
피험자 모집 중
65세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07227077Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06106477E-Mindfulness Approaches for Living After Breast Cancer
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Cancer Care - Berlin, Berlin
- 외 21개
피험자 모집 중3상
18세 ~ 50세 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT06748222Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
- University of Wisconsin Carbone Cancer Center, Madison
피험자 모집 중2상
40세 이상 · 여성 · 2026. 6. 11. 업데이트됨 · NCT03936478De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Langlade Hospital and Cancer Center, Antigo
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- 외 43개
피험자 모집 중3상
50세 ~ 70세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Aspirus Langlade Hospital, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Ascension Saint Elizabeth Hospital, Appleton
- 외 61개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Medical College of Wisconsin, Milwaukee
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 5. 업데이트됨 · NCT04075305Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT02926690Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- University of Wisconsin, Madison
피험자 모집 중4상
18세 ~ 64세 · 모든 성별 · 2026. 1. 22. 업데이트됨 · NCT04373564EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Aurora Cancer Care - Wauwatosa, Wauwatosa
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06401421SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
피험자 모집 중2상
18세 이상 · 여성 · 2025. 10. 14. 업데이트됨 · NCT06361940ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.